News

WICHITA, Kan., and DAVIS, Calif. (June 1, 2016) – Koch Agronomic Services, LLC (Koch), with support from its affiliate, Koch Biological Solutions, LLC, has secured exclusive rights to sell REGALIA® Rx in the U.S. and REGALIA® Maxx in Canada. Koch will market and sell the products for broad-acre agriculture applications. REGALIA® Rx and REGALIA® Maxx are manufactured by Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII) and improve crop performance by providing defense against fungal pests. Both products also offer significant plant health benefits.

MBI is a pioneer in the rapidly growing field of biopesticides, with multiple product lines already in the market. MBI’s products are supported by robust capabilities for discovering, developing and commercializing naturally derived technologies.

“MBI has a proven history of developing biopesticides that offer effective solutions for growers” said Pam Marrone, founder and CEO, Marrone Bio Innovations. “We believe that Koch’s broad-acre agriculture experience and ability to bring products to market will provide more growers the ability to increase their yields with REGALIA® Rx and REGALIA® Maxx on broad-acre row crops.”

Koch Agronomic Services is dedicated to providing fertilizers to increase plant performance that are grounded in science. Koch Agronomic Services has a broad portfolio of enhanced efficiency fertilizer technologies in both the agricultural and turf & ornamental markets including AGROTAIN® nitrogen stabilizer, SUPERU® fertilizer, POLYON® and DURATION® controlled-release fertilizer and UMAXX® stabilized nitrogen among many others.

Koch Biological Solutions has established a strong discovery platform focused on the identification, development and commercialization of biostimulant products that improve plant performance. The company has several promising biological product candidates in various stages of development.

“We’re looking for ways to bring effective, science-based products to the market whether that’s through the development of our own products, or through partnerships with innovators like MBI,” said Bill Boycott, vice president, biologicals and origination, Koch. “Our goal is to provide effective biologicals for our customers and growers. We are very excited about the technology behind REGALIA® Rx and REGALIA® Maxx.”

Additional terms of the deal were not disclosed.

#  #  #

About Koch Agronomic Services, LLC
Koch Agronomic Services, LLC and its affiliates produce and market plant performance solutions for the world’s top agriculture producers and turf and ornamental professionals. Koch Agronomic Services, LLC is committed to delivering exceptional value through a combination of research and development, an innovative product portfolio and outstanding service. Koch Agronomic Services, LLC is a subsidiary of Koch Ag & Energy Solutions, LLC.
www.kochagronomicservices.com

About Koch Biological Solutions, LLC
Koch Biological Solutions, LLC and its affiliates are creating new technologies to satisfy the changing needs of the agricultural industry. Koch Biological Solutions, LLC is focused on biological solutions that increase crop performance through science based products. Koch Biological Solutions, LLC is an affiliate of Koch Agronomic Services, LLC.
www.kochbiologicalsolutions.com

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ: MBII) aims to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market--Regalia®, Grandevo®, Venerate® and Majestene®--and also distribute Bio-tam® 2.0 for Isagro USA. MBI also markets Zequanox® for invasive mussels, a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit
www.marronebio.com

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the market for and sales of the Regalia family of brands and potential benefits of MBI’s collaboration with Koch and Koch’s ability to bring Regalia brands to the broad-acre row crop market. Such forward-looking statements are based on information available to MBI as of the date of this release and involve a number of risks and uncertainties, some beyond the MBI’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including any difficulty in marketing Regalia brands to the broad-acre row crop market with MBI’s principal customers, competition in the market for pest management products and lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

WICHITA, Kan. – An affiliate of Koch Biological Solutions, LLC has acquired a minority equity position in, and entered into collaboration with, Pathway BioLogic, LLC (Pathway). Pathway is a leader in the rapidly growing field of biological plant health solutions, with a specific focus on live microbial products. The company has several proven products in the market focused on enhancing plant health including PowerBlendTM, PowerCoatTM and BioPathTM among others. Pathway’s products are supported by strong fermentation and formulation capabilities.

With the acquisition of certain assets of Mendel Biotechnology, Inc. in December 2014, Koch Biological Solutions established a strong discovery platform focused on the identification, development and commercialization of biostimulant products. Combined, the two entities represent a compelling set of capabilities that will collaborate to bring new biological solutions to the marketplace.

“Working with Pathway allows us to continue building our product development capabilities and establish a strong commercial presence in the market,” said Bill Boycott, vice president biologicals and origination for Koch.

“Pathway’s success is driven by the quality of our people in rallying around a common vision and mission to continue to innovate and develop biological solutions to increase crop productivity” said Michael Gans, director of operations for Pathway BioLogic. “By leveraging our fermentation and formulation capabilities with Koch’s discovery platform and commercialization capabilities, we will create an extremely efficient process to build an industry leading portfolio of science based microbial products.”

Additional terms of the deal were not disclosed.
 

#  #  #

About Koch Biological Solutions, LLC
Koch Biological Solutions, LLC and its affiliates are creating new technologies to satisfy the changing needs of the agricultural industry. Our team is focused on biological solutions that increase crop performance through science based products. Koch Biological Solutions, LLC is a subsidiary of Koch Agronomic Services, LLC.
www.kochagronomicservices.com

About Pathway BioLogic, LLC
Pathway BioLogic, LLC develops and manufactures biological crop solutions that increase crop yield through naturally-derived products, more specifically, Plant Growth Promoting Rhizobacteria (PGPR). We are committed to providing the innovations that will help sustain crops around the world.
www.pathwaybiologic.com

WICHITA, Kan. – As part of an ongoing collaboration, NAICONS has transferred its entire collection of filamentous fungi to Koch Biological Solutions, LLC (dba Mendel Biological Solutions). The fungi collection includes approximately 25,000 fungal isolates. The collection contains a subset of more than 5,000 plant endophytes, mostly originated from endemic plants of the Mediterranean region.

"We are excited about our collaboration with Koch,” says Stefano Donadio, Ph.D., CEO of NAICONS. "The fungi collection will now get the attention it deserves and we look forward to new products originating from it."

"We are looking forward to exploring this unique and extremely diverse collection of fungi from NAICONS,” said Bill Boycott, vice president biologicals and origination for Koch. “Fungi are a potentially significant source of valuable natural ingredients and we look forward to developing novel products from this collection that deliver enhanced performance across a wide range of crops."

For further information about Koch Biological Solutions, please visit http://www.mendel.com/.
 

#  #  #

About Koch Biological Solutions, LLC
Koch Biological Solutions, LLC and its affiliates are creating new technologies to satisfy the changing needs of the agricultural industry. Our team is focused on biological solutions that increase crop performance through science based products. Koch Biological Solutions, LLC is a subsidiary of Koch Agronomic Services, LLC.
www.kochagronomicservices.com

New business platform to focus on research and discovery of biologically based solutions to increase crop yield potential

 A subsidiary of Koch Agronomic Services, LLC (KAS), announced today that it has purchased the biological research and development business of Mendel Biotechnology, Inc. The business will operate as Mendel Biological Solutions and will continue to be based in Hayward, Calif.

Mendel’s biological research and development team focuses on biological crop solutions which increase crop yield potential through the use of naturally derived products. The acquisition establishes a new biological platform for KAS, furthering its commitment to develop innovative technologies that satisfy evolving needs of the agricultural industry.

“As global population increases so does food demand, and growers are challenged to produce more crops to meet the need,” said Bill Boycott, KAS vice president of biologicals. “The Mendel team has expertise in understanding how plant processes, such as photosynthesis, stress tolerance and nutrient use efficiency, impact crop yields. By integrating Mendel’s research expertise with our commercialization capabilities, we will offer customers a new line of naturally derived products.”

Greg Ikonen, interim CEO of Mendel, added, “We are excited to join KAS and play a part in its vision to develop new biological products that will better serve customers’ changing needs.”

Financial details of the agreement are not being disclosed. Kirchner and Company, the M&A arm of the Kirchner Group, acted as the advisor to Mendel Biotechnology, Inc.